![Michael Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Burgess
Directeur/Membre du Conseil chez
iOmx Therapeutics AG
Profil
Michael M.
Burgess currently works at The Royal College of Physicians, as Member, The Royal College of Paediatrics & Child Health, as Member, and iOmx Therapeutics AG, as Member-Supervisory Board from 2022.
Dr. Burgess also formerly worked at Turnstone Biologics Corp., as Director from 2024 to 2025, Synlogic, Inc., as Independent Director from 2020 to 2024, Bristol Myers Squibb Co., as SVP-Discovery Medicine & Clinical Pharmacology, Roche Holding AG, as Head-Oncology Discovery & Translational Area in 2012, Hoffmann-La Roche, Inc., as Global Head-DTA Oncology Division, Roche Holding (UK) Ltd., as Head-Clinical Research Division in 2010, Roche Ltd., as Head-Oncology Discovery & Translational Area, and Springworks Therapeutics, Inc., as Head-Research & Development from 2021 to 2022.
Dr. Burgess received his graduate degree in 1989 from the University of Bristol and doctorate degree in 1999 from the University of Bristol.
Postes actifs de Michael Burgess
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur/Membre du Conseil | 20/07/2022 |
Anciens postes connus de Michael Burgess
| Sociétés | Poste | Fin |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Directeur Technique/Scientifique/R&D | 01/11/2024 |
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 20/03/2024 |
| SPRINGWORKS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 16/09/2022 |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Corporate Officer/Principal | 01/01/2010 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formation de Michael Burgess
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
